4Coetzee EJ, Dommisse J, Anthony J. A randomized controlled trial of intravenous magnesium sulphate versus placebo in management of women with severe preeclampsia [ J ]. BJOG, 1998,105:300 - 303.
1Vane KM, Sheiner E, Levy A, et al. Chronic hypertension and the risk for adverse pregnancy outcome after superimposed preeclampsia[ J]. Int J Gynaecol Obstet,2004,86( 1 ) :7-11.
3Kadyrov M, Kingdom JC, Huppertz B. Divergent trophoblast invasion and apoptosis in maternal anemia and early-onset preeclampsia/in trauterine growth restriction [ J ]. Am J Obstet Gynecol,2006,194 (2) :557- 553.
5Hall DR. Early severe pre-eclampsia and delivery at 34 weeks' gestationor earlier[ J ]. Obstet Gynecol,2005,88 ( 1 ) :57-58.
6Hall DR , Odendaal HJ , Steyn DW, et al. Expectant management of early onset severe pre-eclampsia : maternal outcome [ J ]. Br J Obstet Gyneco,2000,107 (10) : 1252-1255.
7Withagen MI , Wallenburg HC , Steegers EA , et al . Morbidity and development in childhood of infants born after temporising treatment of early onset pre-eclampsia [ J ]. B JOG,2005,112 ( 7 ) :910-914.
8Mutter WP, Karumanchi SA. Molecular mechanisms of pre-eclampsia[J]. Microvasc Res,2008,75( 1 ) : 1-8.
9Stepan H, Geipel A, Schwarz F,et al. Circulatory soluhleendoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion [ J ]. Am J Obstet Gynecol,2008,198(2) :175. e1-6.
10Pattinson RC, Odendaal HJ, du Toit R. Conservative management of severe proteinuric hypertension before 28 weeks'gestation[J]. S Afr Med J, 1988 , 73(9) 1516-518.
